Cargando…
Notch signaling as a therapeutic target for breast cancer treatment?
Aberrant Notch signaling can induce mammary gland carcinoma in transgenic mice, and high expressions of Notch receptors and ligands have been linked to poor clinical outcomes in human patients with breast cancer. This suggests that inhibition of Notch signaling may be beneficial for breast cancer tr...
Autores principales: | Han, Jianxun, Hendzel, Michael J, Allalunis-Turner, Joan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218932/ https://www.ncbi.nlm.nih.gov/pubmed/21672271 http://dx.doi.org/10.1186/bcr2875 |
Ejemplares similares
-
The cytotoxicity of γ-secretase inhibitor I to breast cancer cells is mediated by proteasome inhibition, not by γ-secretase inhibition
por: Han, Jianxun, et al.
Publicado: (2009) -
The many facets of Notch signaling in breast cancer: toward overcoming therapeutic resistance
por: Nandi, Ajeya, et al.
Publicado: (2020) -
Therapeutic Targeting of Notch Signaling Pathway in Hematological Malignancies
por: Sorrentino, Claudia, et al.
Publicado: (2019) -
Dll4-Notch signaling as a therapeutic target in tumor angiogenesis
por: Kuhnert, Frank, et al.
Publicado: (2011) -
Notch Signaling in Endothelial Cells: Is It the Therapeutic Target for Vascular Neointimal Hyperplasia?
por: Tian, Ding-Yuan, et al.
Publicado: (2017)